Clinical Trials Logo

Clinical Trial Summary

This longitudinal study aims to countervail age-related cognitive and cerebral decline in healthy retired people through intensive piano / keyboard music practice in Switzerland and Germany.


Clinical Trial Description

Recent data suggest that music making might prevent cognitive decline in the elderly. However, experimental evidence remains sparse and no information on the neurophysiological basis has been provided, although cognitive decline is a major impediment to healthy aging. This study combines for the first time protocolled music practice in elderly with cutting-edge neuroimaging. The investigators propose a multi-site Hannover-Geneva longitudinal randomized intervention study in altogether 100 retired healthy elderly (64-76) years, 70 Geneva, 100 Hannover), offering either piano instruction or instruction on musical culture for one year. Participants will be tested at 3 time points on cognitive, perceptual and motor abilities as well as via wide-ranging functional and structural neuroimaging data (Magnetic Resonance Imaging, MRI). The research team expects positive transfer effects from intensive piano training not only on subjective well-being, but also on executive functions, working memory, hearing in noise and relationships of these behavioral features with morphological and functional brain plasticity. This study may therefore for the first time be demonstrate, that music making can provoke important societal impacts by diminishing cognitive and perceptual-motor decline underpinned by functional and structural brain plasticity. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03674931
Study type Interventional
Source School of Health Sciences Geneva
Contact
Status Completed
Phase N/A
Start date April 1, 2018
Completion date July 31, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04121728 - Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT03228446 - The Effects of Attentional Filter Training on Working Memory N/A
Completed NCT04910399 - Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging N/A
Recruiting NCT03275363 - The University of Hong Kong Neurocognitive Disorder Cohort N/A
Completed NCT02185222 - Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint Phase 3
Completed NCT03162913 - The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults N/A
Completed NCT02416401 - Attention Training for Learning Enhancement and Resilience Trial N/A
Completed NCT02922920 - Effects of Tart Cherry Juice on the Body N/A
Completed NCT01120860 - Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator Performance N/A
Recruiting NCT03702335 - Impact of Comprehensive Dietary Counseling on Dietary Quality, Mental Health, and Quality of Life in Older Adults N/A
Completed NCT05828043 - Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline N/A
Active, not recruiting NCT05348694 - OsteoPreP: Food Supplements for Postmenopausal Bone Health Phase 4
Recruiting NCT05194787 - TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Recruiting NCT04184375 - Cognitive Stimulation for Elderly Bipolar Patients N/A
Recruiting NCT04171323 - The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia N/A
Not yet recruiting NCT06248723 - ItaliaN Study With Tailored Multidomain Interventions to Prevent Functional and Cognitive Decline in Community-dwelling Older Adults N/A
Terminated NCT04732312 - Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment
Recruiting NCT06377254 - Multi-organ Responses to CHronic Physical Activity and INactivity N/A
Not yet recruiting NCT04566757 - Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline Phase 1